Journal article

Preparation and testing of homocubyl amines as therapeutic NMDA receptor antagonists


Authors listSklyarova, AS; Rodionov, VN; Parsons, CG; Quack, G; Schreiner, PR; Fokin, AA

Publication year2013

Pages360-366

JournalMedicinal Chemistry Research

Volume number22

Issue number1

DOI Linkhttps://doi.org/10.1007/s00044-012-0029-7

PublisherSpringer


Abstract

Computational modeling demonstrates that the van-der-Waals surfaces of homocubyl amines are similar to that of the neuroprotector Memantine®. Utilizing readily available precursors we report the preparation of a series of homological cubylamines, namely
pentacyclo[6.3.0.02,6.03,10.05,9]undecyl-4-amine (trishomocubyl-4-amine, 2), pentacyclo[5.3.0.02,5.03,9.04,8]decyl-10-amine (bishomocubyl-10-amine, 3), pentacyclo[4.3.0.02,5.03,8.04,7]nonyl-9-amine (homocubyl-9-amine, 4), and pentacyclo[4.2.0.02,5.03,8.04,7]octyl-1-amine (cubylamine, 5). The hydrochlorides of amines 25 show pronounced affinity for the (+)MK-801 channel binding site, and it seems likely that these compounds would act as very fast voltage-dependent NMDA receptor antagonists.




Citation Styles

Harvard Citation styleSklyarova, A., Rodionov, V., Parsons, C., Quack, G., Schreiner, P. and Fokin, A. (2013) Preparation and testing of homocubyl amines as therapeutic NMDA receptor antagonists, Medicinal Chemistry Research, 22(1), pp. 360-366. https://doi.org/10.1007/s00044-012-0029-7

APA Citation styleSklyarova, A., Rodionov, V., Parsons, C., Quack, G., Schreiner, P., & Fokin, A. (2013). Preparation and testing of homocubyl amines as therapeutic NMDA receptor antagonists. Medicinal Chemistry Research. 22(1), 360-366. https://doi.org/10.1007/s00044-012-0029-7


Last updated on 2025-21-05 at 14:53